Christopher Yea - CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
KALV on Nasdaq
All Insider Reports
All Insider Reports

Christopher Yea - trading volume in the past year for KalVista Pharmaceuticals, Inc.

Holdings reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 134K $1.93M $14.48 Nov 18, 2025 Direct
Restricted Stock Unit 0 $399K $9.82 Nov 17, 2025 Direct Common Stock
Performance Stock Units 0 $0 $9.26 Nov 17, 2024 Direct Common Stock

Transactions reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.